Interventions: None. Measurements and Main Results: Demographic and clinical data concerning the first 24 hours after ICU admission were obtained. Patients were followed until February 2016 to assess long-term survival. Functional outcome was determined using the modified Rankin Scale. We evaluated 131 critically ill stroke patients, with a median (interquartile range) age of 70 years (55-78 yr). One-year mortality rate was 52.7%. Surviving patients were followed up over a median (interquartile range) period of 4.3 years (4.0-4.8 yr). The multivariable model that best predicted long-term all-cause mortality indicated that mortality of critically ill stroke patients was predicted by high Acute Physiology and Chronic Health Evaluation II score, impaired consciousness (Glasgow Coma Scale score ≤ 8) as reason for ICU admission, low Glasgow Coma Scale sum score after 24 hours, and absence of brainstem reflexes. Longterm independent functional status occurred in 30.9% of surviving patients and was predicted by low Acute Physiology and Chronic Health Evaluation II score, high Glasgow Coma Scale sum score at ICU admission, and absence of mass effect on CT scan. Conclusions: Mortality in critically ill stroke patients is high and occurs most often shortly after the event. Less than one in three surviving patients is able to function independently after 1 year. This study has identified several clinical variables that predict long-term all-cause mortality and functional outcome among critically ill stroke patients and found that mainly acute physiologic disturbance and absolute values of neurologic clinical assessment are predictive. (Crit Care Med 2018; 46:1085-1092 Key Words: critical care; functional outcome; intensive care unit; mortality; stroke; survival S troke is a major healthcare issue worldwide despite the fact that the occurrence rate of stroke and subsequent mortality are declining over time (1). Although global age-standardized death rates have decreased by 19.6% for ischemic and 25.9% for hemorrhagic stroke from 1990 to 2013 (2), stroke is still the fourth leading cause of mortality in the
United Kingdom with an age-standardized annual incidence of 85 and 30 per 100,000 person-years for respectively ischemic and hemorrhagic stroke (3) .
Optimal in-hospital placement for acute stroke patients (4) (5) (6) (7) (8) and treatment decisions concerning (mainly acute ischemic) stroke patients (9) (10) (11) (12) (13) (14) (15) have been widely discussed during the past decades. Patients with severe stroke can be seriously compromised with respect to vital organ function compared with other neurologic patients, and they may need to be treated in the ICU (16) . Furthermore, due to the increasing complexity of stroke treatment, the future of acute stroke care and the role of critical care will be increasingly intertwined (17) . Neurologic dysfunction is a frequent reason to initiate ICU treatment and may be the result of a variety of causes (18) . Of these, structural brain lesions such as stroke generally predict the worst prognosis and present the greatest challenge to clinicians (19) .
The long-term consequences of stroke in terms of mortality and morbidity have been investigated thoroughly. Morbidity in terms of functional outcome is generally reported by the seven-level ordered categorical modified Rankin Scale (mRS) (20, 21) . The mRS is widely applied and validated as a clinically relevant instrument for assessing recovery from stroke and is a valuable endpoint in stroke studies (22) . However, stroke research concerning survival and functional outcome is often performed in a general population of stroke patients, and dates from before more invasive treatment modalities became standard (9) (10) (11) (12) (13) (14) (15) . Unfortunately, much less is yet known about poststroke outcome in the subset of patients in need of ICU admission.
Therefore, we conducted this long-term follow-up study to determine the clinical variables measured upon ICU admission that predict long-term survival and functional outcome (measured by mRS) of adult stroke patients admitted to the ICU.
MATERIALS AND METHODS

Study Population
All adult patients admitted via the emergency department to either the general or neurosurgical ICU of one of the University College London Hospitals (UCLH) in North Central London between February 2010 and May 2012 with a clinical diagnosis of acute ischemic or intracerebral hemorrhagic stroke, confirmed by noncontrast cranial CT scan, were included. This 2-year time frame for data collection was particularly chosen because it was after the introduction of the hyperacute stroke unit pathway, in which rapid administration of thrombolytic agents, when indicated, had been implemented in the UCLH. Consequently, patients were followed until February 2016 to assess long-term survival.
Data were collected for quality trust audit purposes. The study was exempt from approval per the local ethics committee as part of an audit of the stroke care pathway. Demographic and clinical data were obtained from the national, trust, and hospital databases. Patients who met at least one of the following criteria were excluded from the study: subarachnoid or subdural bleeding, known intracerebral or intracerebellar tumor, in-hospital stroke, and referral from another ICU for the same diagnosis.
Data Collection
We tabularized patient's age, gender, time of admission, interval between stroke onset and hospital arrival, reason for ICU admission, prior illnesses, and Acute Physiology and Chronic Health Evaluation (APACHE) II with range of scores 0-71 (23) . Data on vital variables and neurologic examination were recorded, as well as laboratory results, CT angiography, and treatment strategies including interventions. All collected data contained information concerning the first 24 hours after ICU admission.
Respiratory variables were collected beyond the scope of the first 24 hours after ICU admission and included clinical diagnosis of pneumonia during ICU stay, whether patients were intubated during ICU stay and, if so, duration of mechanical ventilation and whether tracheostomy was performed. Functional outcome using mRS was obtained from the medical record draughted by the primary treating physician, mostly a neurologist or neurosurgeon, at hospital discharge and at 1-year follow-up check appointment.
Statistical Analyses
The primary outcome measure was stated as all-cause longterm poststroke mortality. Surviving patients were censored on February 20, 2016. Cumulative risks were assessed by KaplanMeier analysis, and prognostic factors for long-term all-cause poststroke mortality were determined by Cox proportional hazards (PH) regression analyses with data presented as hazard ratio (HR) with 95% CIs. Log minus log plots were used to confirm proportionality of hazards assumption over time. Secondary outcome measures were stated as good functional outcome (mRS, 0-2; independent functional status) versus poor functional outcome (mRS, 3-6; dependent functional status or dead). Furthermore, change in mRS was taken into account, defined as improved functional status (mRS equal or increased between hospital discharge and after 1 yr) versus declined functional status (mRS decreased between hospital discharge and after 1 yr). Prognostic factors for functional outcome and change in functional status were determined with binary logistic regression with data presented as odds ratio (OR) with 95% CI.
In both primary and secondary outcome analyses, all univariable predictor variables with a p value of less than 0.1 were entered into a multivariable regression model. The maximum amount of predictive variables considering the amount of outcome events was taken into account. Multiple imputation with 50 repetitions was applied for the multivariable Cox PH analysis and multiple binary logistic regression analyses in case of missing covariates. Model development was performed by applying the backward stepwise selection procedure on the multiple imputed dataset (24) (25) (26) . A probability value of 0.05 or less was considered as significant. All statistical analyses were performed using SPSS Statistics for Macintosh version 25.0 (IBM, Armonk, NY).
RESULTS
Patient Characteristics
During the study period, 131 acute stroke patients were admitted to the ICU with a median age of 70 years of which 76 (58.0%) were male. Main reason for ICU admission was impaired consciousness (Glasgow Coma Scale [GCS] ≤ 8) (52.7%). The median (interquartile range) length of stay in ICU and in-hospital was respectively 3 days (1-6 d) and 9 days (4-25 d). Demographic and clinical patient characteristics are presented in Table 1 .
Type of Stroke and Interventions
Seventy-five patients (57.3%) suffered an ischemic stroke, of which 41 (54.7%) received IV thrombolysis. Six of them underwent interventional thrombolysis as well. Fourteen ischemic stroke patients (18.7%) received neurosurgical intervention: two underwent ventriculostomy, seven patients underwent decompressive hemicraniotomy, and five patients received an intravascular stent. Of the 56 hemorrhagic stroke patients, thirteen patients (23.2%) received neurosurgical intervention: seven underwent ventriculostomy and six patients underwent decompressive hemicraniotomy. Figure 1 shows a flowchart of the patients alive over time during the study period. Eighty-seven patients survived ICU stay, of which 72 were discharged from the hospital alive. One-year mortality rate was 52.7%. Seventy-seven critically ill stroke patients (58.8%) died during the study period. Surviving patients (41.2%) were followed up over a median (range) period of 4.3 years (3.8-6.0 yr).
Survival Rates and Distribution
One in four patients that deceased during the study period died within 2 days after the event. Thirty-nine patients (50.6% of the 77 deceased patients) died within a week. Survival was charted by the Kaplan-Meier method shown in Figure 2 , displaying most deceased patients died shortly after the event. The results of the multivariable Cox PH regression analysis are shown in Table 3 . The multivariable model that best predicted long-term all-cause poststroke mortality contained high APACHE II score, impaired consciousness (GCS score ≤ 8) as reason for ICU admission, low GCS sum score after 24 hours, and absence of brainstem reflexes. For every point higher on the APACHE II score, mortality increased by 11.9% (HR, 1.12; 95% CI, 1.07-1.17). When impaired consciousness (GCS score ≤ 8) was the reason for admission, patients had a three-fold chance to die (HR, 3.05; 95% CI, 1.08-8.66). For The multiple binary logistic regression that best predicted "improvement in functional outcome" from hospital discharge during follow-up after 1 year contained only APACHE II score as predicting variable. For every point higher on the APACHE II score, chance for improvement in functional outcome decreased by 13% (OR, 0.87; 95% CI, 0.78-0.97).
Predictors of Mortality
DISCUSSION
We have studied a cohort of 131 critically ill stroke patients for a period of more than 4 years aiming to aid in the identification of ICU-admitted stroke patients who are at increased risk of death or poor functional outcome. Our results show that mortality in critically ill stroke patients is high, and most deceased patients die shortly after the event. Long-term allcause mortality of critically ill stroke patients is predicted by high APACHE II score, impaired consciousness (GCS ≤ 8) as reason for ICU admission, low GCS sum score after 24 hours, and absence of brainstem reflexes. Independent functional status occurs in less than one in three (30.9%) surviving critically ill stroke patients after 1 year follow-up. Poor functional outcome is predicted by high APACHE II score and presence of mass effect on CT scan.
Our hospital and 1-year mortality rates of respectively 45.0% and 52.7% lie well within the widely varying range reported in earlier studies (16, (27) (28) (29) (30) (31) (32) (33) . However, earlier literature does not elaborate poststroke survival probabilities beyond 1 year after onset. Due to our extensive follow-up period, this study shows that mortality rates of critically ill stroke survivors after the first year of onset are rather low with an average annual mortality rate of 3.4% in our study cohort, which is comparable with ICU-admitted patients due to subarachnoid hemorrhage 1 year after onset or even a representative general population group (34) . The mean age of our study group of 70 years and the higher chances for mortality in the older age groups correspond to earlier study cohorts (16, (27) (28) (29) (30) (31) (32) (33) . In our study, cohort type of stroke does not predict mortality, which is inconsistent with earlier literature (16, 27) . These earlier studies had different distributions of type of stroke within their populations and were conducted before the introduction of specialized care units for stroke and rapid IV thrombolysis and intra-arterial thrombosuction for ischemic stroke patients. These evolving treatment possibilities may cause a pleiotropic effect on the current distribution and mortality rates of critically ill stroke patients, due to patient selection for these treatments but also their possible complications. In general, the inevitable effect of a long-term follow-up study is that the study population at the start of the study might not have received the treatment available at the end of the accrual period. However, the patients in our study cohort suffered a stroke during the time that new treatment possibilities were available and had been introduced and applied in clinical practice. Our low proportion of hemicraniectomies (9.3%) indicates that our population is comparable with a more recent cohort where the frequency of hemicraniectomy (8.2%) was measured with an inverse correlation between the use of neurointerventional thrombectomy and the number of hemicraniectomy being carried out (35) . The strength of our study lies in the extensive follow-up time and in the fact that we have used variables that describe the clinical and neurologic status at ICU admission and their change in the first 24 hours following ICU admission to predict long-term all-cause mortality and functional outcome. Therefore, this study can be helpful to identify the critically ill stroke patients who are at increased risk of death and to estimate their long-term functional status. Our findings may help clinicians in their information transfer to families and patients about patterns of survival probabilities. A limitation of this study is its retrospective design with inherent biases and shortcomings, including issues concerning possibility of misclassification and missing data. This study was conducted as a quality trust audit on an ICU with elaborate and meticulous recordkeeping including results of diagnostic and therapeutic interventions, GCS at admission, and during follow-up. Therefore, we hope to have reduced the possibility of misclassification with respect to diagnosis, intervention, and follow-up. Furthermore, if missing data were present, we used multiple imputation with 50 repetitions in order to minimize the effect on our results. The study was performed in a population of modest sample size, accrued in a single center in a highly populated urban region, and the study has therefore limited external validity. In order to keep our survival prediction model as precise and distinct as possible with a small time frame of only the first 24 hours after ICU admission, necessity and duration of mechanical ventilation during ICU stay, both well-known predictors for mortality in critically ill stroke patients (6, 19, 36, 37) , were not incorporated in our multivariable analyses. Unfortunately, we were not able to collect National Institutes of Health Stroke Scale scores and data concerning withdrawal of care, quality of postacute in-hospital care and posthospital facilities. In the functional outcome analyses, seven patients were lost to follow-up after 1 year and we did not incorporate the admittance and possible impact of rehabilitation on functional outcome. Furthermore, we focused our research on ICU patients with the possible disadvantage of not including and analyzing acute stroke patients admitted to the emergency department but not to the ICU, due to lack of necessity of ICU care on one side or lack of estimated benefit on the other side. Unfortunately, we were not able to compare the neurologic and general status of our study cohort with stroke patients who were not admitted to the ICU and therefore not able to exclude a possible selection bias. With these methodological shortcomings in mind, our results therefore only pertain to the subset of acute stroke patients who are so critically ill that ICU admission is needed.
CONCLUSIONS
Stroke incidence and subsequent poststroke mortality have declined in recent years attributable to improved risk factor management and treatment options. However, still half of all critically ill stroke patients do not survive the first year after the event. This study has identified several clinical variables that predict long-term all-cause mortality and functional outcome among critically ill stroke patients and found that mainly acute physiologic disturbance and absolute values of neurologic clinical assessment were predictive. These results can be the first step toward a clinically applicable survival prediction model in order to realize a decision support algorithm. However, the design of this study does not allow to completely fulfill this intent nor does it help to distinguish the variables with a direct pathophysiologic role in poststroke mortality. These issues require assessment and validation in a larger and prospective multicenter study.
